BIM
BlackRock Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $124M | Sell |
339,110
-242,010
| -42% | -$88.8M | 0.14% | 140 |
|
2016
Q3 | $234M | Buy |
581,120
+177,702
| +44% | +$71.4M | 0.29% | 70 |
|
2016
Q2 | $141M | Buy |
403,418
+232,471
| +136% | +$81.2M | 0.18% | 119 |
|
2016
Q1 | $61.6M | Sell |
170,947
-7,274
| -4% | -$2.62M | 0.08% | 241 |
|
2015
Q4 | $96.8M | Buy |
178,221
+1,306
| +0.7% | +$709K | 0.12% | 165 |
|
2015
Q3 | $82.3M | Sell |
176,915
-2,589
| -1% | -$1.2M | 0.11% | 186 |
|
2015
Q2 | $91.6M | Sell |
179,504
-132,096
| -42% | -$67.4M | 0.11% | 182 |
|
2015
Q1 | $141M | Sell |
311,600
-101,984
| -25% | -$46M | 0.18% | 118 |
|
2014
Q4 | $170M | Sell |
413,584
-126,401
| -23% | -$51.9M | 0.22% | 103 |
|
2014
Q3 | $195M | Sell |
539,985
-97,924
| -15% | -$35.3M | 0.27% | 80 |
|
2014
Q2 | $180M | Buy |
637,909
+248,105
| +64% | +$70.1M | 0.24% | 87 |
|
2014
Q1 | $117M | Sell |
389,804
-44,767
| -10% | -$13.4M | 0.17% | 125 |
|
2013
Q4 | $120M | Buy |
434,571
+188,548
| +77% | +$51.9M | 0.18% | 118 |
|
2013
Q3 | $77M | Buy |
246,023
+113,514
| +86% | +$35.5M | 0.13% | 160 |
|
2013
Q2 | $29.8M | Buy |
+132,509
| New | +$29.8M | 0.05% | 325 |
|